New Womble Carlyle Life Science Attorneys Make Law360, Law.com
October 12, 2012
Law360 and Law.com both published a lengthy story about five new Life Science/IP Litigation attorneys joining Womble Carlyle.
Earlier this month, attorneys Mary Bourke, Mark Pino, Kristen Cramer, Dana Severance and Daniel Attaway joined the firm, greatly increasing Womble Carlyle’s life science litigation capabilities.
“We feel that we have all of the major technical areas within life sciences well covered; the one area that we were working toward was a preeminent life sciences litigation practice,” Jim Vaughan, leader of Womble Carlyle’s Intellectual Property Practice Group, told Law360. Vaughan said these additions “(place) our life sciences transactional and litigation capabilities up there as significant as anyone's in the country.”
The new attorneys are as follows:
Mary Bourke focuses her practice on patent litigation in the pharmaceutical and biotech industries. She was the co-first chair for Pfizer’s successful defense of Lipitor® against several ANDA filers. Additionally, Mary currently represents Astra Zeneca in multiple litigations involving AstraZeneca’s successful drug CRESTOR®. Bourke has more than 20 years of patent litigation experience. She practices in Womble Carlyle’s Wilmington, Del. office.
Mark Pino concentrates his practice on patent prosecution and counseling in the area of pharmaceutical, biotech and chemical patents. He also counsels clients in ANDA litigation and International Trade Commission proceedings. His scientific background includes experience with small molecules, pharmaceuticals, formulations, organic chemistry, peptides, chemical manufacturing processes, inorganics and polymers. He practices in Womble Carlyle’s Washington, D.C. office.
Kristen Cramer has 10 years of patent litigation experience, representing clients in areas including biotechnology, pharmaceuticals, medical devices, consumer electronics, computer networks, and business methods. Cramer represents international companies as lead and as Delaware counsel in district and appellate actions involving pharmaceuticals and medical devices. She practices in the firm’s Wilmington, Del. office.
Dana Severance represents clients in patent litigation relating to pharmaceutical and biotech matters. Her focus is on ANDA litigation for the pharmaceutical industry as well as handling large e-discovery matters. She practices in the firm’s Wilmington, Del. office.
Daniel Attaway represents clients in patent litigation, prosecution and counseling, and trademark litigation in the chemical and pharmaceutical industries. He focuses primarily on ANDA litigation for the pharmaceutical industry as well as overseeing large-scale document review projects. Prior to his legal career, he was a process and production engineer for Lyondell Chemical Company. Attaway practices in the firm’s Wilmington, Del. office.
Click here to read the Law360 article (subscription required).
Click here to read the Law.com article (originally published in Delaware Law Weekly).